Skip to content
Head to head

SS Innovations International vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: SSII · ABT

Updated moments ago

1-year performance, rebased to 100

SSII -79.9%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories has the highest Quant Rating (22); Abbott Laboratories has done best over the past year (-15%); Abbott Laboratories pays the highest dividend yield.
SSIIABT
Snapshot
Sector--Medical Devices
Last price1.27103.00
Change today-0.78%-0.84%
1-year return-78.7%-15.4%
Market cap$254.86M$178.39B
52-week range1.12 – 6.7980.89 – 126.70
Valuation
P/E (TTM)-18.1438.29
P/E percentile, own 5-yr range85th99th
P/B5.103.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)-0.063.72
Net profit (TTM)$-12.04M$6.44B
Revenue (TTM)$52.40M$48.23B
Provider revenue period date2026-06-292026-09-29
Revenue growth (YoY)+39.4%+14.5%
Gross margin47.6%56.9%
Operating margin-16.2%13.8%
Net margin-23.7%9.7%
Free cash flow (TTM)$-18.22M$6.76B
Provider cash-flow period date2026-06-292026-09-29
Ownership & sentiment
Institutional ownership8.5%81.2%
Insider activity (12mo)19 buy / 28 sell36 buy / 12 sell
Short interest (% of float)0.0%1.1%
Analyst consensus--93% buy / 7% hold (15)
Analyst price target--$122 (+18%)
StockVane view
StockVane Quant RatingE (1)D (22)
Company
Employees483115,000
Founded20151900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.